Bioperfectus
Taizhou
About Bioperfectus
BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010. BioPerfectus, located in Taizhou; having talented professional R&D, marketing and service network through headquarter and branch offices in Shanghai, Beijing and Xian. Specialized in real time PCR kits, nucleic acid extractions, rapid tests, automation laboratory devices. Missioned by social responsibility of humanity needs, we develop advance technologies to provide reliable, accurate and high-quality products and fast response to any infectious diseases globally. BioPerfectus has manufacturing centers, certified by international known quality standards, covering over 30000 sqm and efficiently distributing products all around the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Funding stage: IPO
- Last round: Series B (May 2016)
- Ticker: sse:688399
- Website: bioperfectus.com
- Phone: 86-021 3463 6754
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bioperfectus-1689163 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.